Showing results (221-230 of 9,974) with videos related to
Sort By:
Pageof 998
Leukemia & Lymphoma|December 6, 2021
RIPK1 inhibition enhances the therapeutic efficacy of chidamide in FLT3-ITD positive AML, both in vitro and in vivoJun Li, Dan Liao, Fujue Wang, et al.Leukemia & Lymphoma|November 21, 2018
Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioningKaito Harada, Masamitsu Yanada, Shinichiro Machida, et al.Leukemia & Lymphoma|February 20, 2019
Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in patients with previously untreated multiple myeloma: the VCAT studyNoemi Horvath, Andrew Spencer, Melita Kenealy, et al.Leukemia & Lymphoma|March 9, 2019
Clinical impact of Internet-based tools to guide therapeutic decisions for mantle cell lymphomaSrinivasa N Gopalsamy, Kristen M Rosenthal, Amy A Ayers, et al.Leukemia & Lymphoma|March 9, 2019
Predictors of early hemorrhage in acute promyelocytic leukemiaLeonard Naymagon, Erin Moshier, Douglas Tremblay, et al.Leukemia & Lymphoma|April 6, 2019
Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemiaHervé Dombret, Max S Topp, Andre C Schuh, et al.Leukemia & Lymphoma|March 27, 2019
Meat, fish, dairy products and risk of hematological malignancies in adults - a systematic review and meta-analysis of prospective studiesTheodoros N Sergentanis, Ioannis Ntanasis-Stathopoulos, Ioannis-Georgios Tzanninis, et al.Leukemia & Lymphoma|September 15, 2019
CD8+ T-cells of CLL-bearing mice acquire a transcriptional program of T-cell activation and exhaustionLaura Llaó Cid, Bola S Hanna, Murat Iskar, et al.Leukemia & Lymphoma|August 15, 2019
Treatment patterns and deep molecular response in chronic phase - chronic myeloid leukemia patients treated with second-line nilotinib or dasatinib: a multi-country retrospective chart review studyJorge Cortes, Lynn Huynh, Estella Mendelson, et al.Leukemia & Lymphoma|January 29, 2021
Measurable residual disease in multiple myeloma and light chain amyloidosis: more than meets the eyeIuliana Vaxman, Morie A GertzPageof 998